Midterm Flashcards
1.Approach to the Surgical Patient
- Chief complaint
- History of present illness
- pain
- vomiting
- change in bowel habits
- hematemesis,rectal bleeding
- trauma
- Past Medical history
- drugs,ROS
- Past surgical history
- OB/GYN history
- Social and family history
1.1.Approach to the Surgical Patient
- Physical examination
- Elective surgical examination
- Examination of body orifices
- <c>ABCDE
<ul>
<li>
<strong>C</strong>atastrophic Haemorrhage control</li>
<li>
<b>A</b>irway (cervical spine control when appropriate)</li>
<li>
<strong>B</strong>reathing</li>
<li>
<b>C</b>irculation</li>
<li>
<strong>D</strong>isability</li>
<li>
<strong>E</strong>xtremity-environment-exposure</li>
</ul>
</c>
1.2.Approach to the Surgical Patient
- Provisional diagnosis
- most probable diagnosis so far
- Differential diagnoses
- list of probable diagnoses to rule out
- Lab & other studies
- blood tests
- urine tests
- functional studies : ECG etc
- Imaging test
- X-ray
- ultrasound
- CT,MRI
- Special investigations
- colonoscopy
- angiography
- cytoscopy
2.Types of Healing
Primary healing (first intention)
- Tissue is clean
- Reapproximation with sutures
- Healing without complication, minimal scarring
Secondary Healing (second intention)
- Infected wounds & burns
- Open wound
- Formation of granulation tissue
Delayed primary closure (third intention)
- Secondary healing for 5 days
- Then primary closure
3.Granulation Tissue
- Red,moist,granular tissue
- Appears during healing of open wounds
- Microscopy : collagen, new blood vessels, fibroblasts, inflammatory cells
- Healing achieved by creation of scar tissue
4.Wound Healing
Hemostasis & Inflammation
- 0-5th day after injury
- Platelet aggregation to exposed subendothelial collagen (IGF-1,TNFa,b, PDGF)
- Coagulation cascade: fibrin clot⇒ coagulation &scaffolding
- Chemotaxis : Damaged endothelial cells ⇒ activation of complement components
- Inflammatory cells :
- Neutrophils & monocytes 24-48h : rolling and adhesion
- Macrophages 48-96h
- T-lymphocyes peak at 7 days
4.1.Wound Healing
Proliferation
- 4-14 days
- Fibroblast replication
- Platelets release PDGF,IGF-1,TGFb
- Macrophages and fibroblasts release FGF,IGF-1,VEGF,IL-1,2,8, PDGF, TGFa,b
- Fibroblasts produce collagen and proteoglycans
4.2.Wound Healing
Angiogenesis
- 2nd to 4th day after injury
- Response to chemoattractants from platelets and macrophages
- PDGF,FGF,TNFa,b,VEGF
4.3.Wound Healing
Epithelization
- starts from wound edges
- Low PO2⇒TGFb from epithelial cells⇒blocks differentiation and promotes mitosis
- Wound needs to be moist to promote epithelization
- Exudate contains : growth factors and lactate
4.4.Wound Healing
Maturation & Remodeling
- 8d-months
- Fibroblasts replace fibrin ECM with collagen monomers⇒polymerization and cross-linking
- ECM evolution : fibronectin, collagen III,glycosaminoglycans,proteoglycans,collagen I
- Remodeling⇒collagen lysis and turnover (MPPs)
- Collagen deposition>>collagen lysis
- Fibroblasts attach to collagen fibres⇒wound contraction
- Negative effect of contraction⇒deformation,stricture
- Wound stretching if tension>>contraction
4.5.Wound Healing
Completion of Healing
- Lactic acidosis and hypoxia normalization⇒stopping of healing
- Keloids : hypertrophic scars due to local overgrowth of CT
Impaired healing
- inadequate inflammatory response : corticosteroids,immunosuppressants,chemotherapeutic drugs
- Excessive inflammation
- Malnutrition (weight loss,hypoalbuminemia)
5.Healing of Specialized Tissues
Bone
- Inflammation
- Proliferation : specialized granulation tissue (fibrocartilaginous callus)
- osteoclasts
- osteoblasts
- chondroblasts
- Bone remodeling
5.1.Healing of Specialized Tissues
Nerve
- Brain⇒CT scar
- Peripheral nerves⇒sheath&axon regenerates from the nerve cell but reconnects randomly distally
5.2.Healing of Specialized Tissues
Intestine
- 4-7th day : risk of anastomotic leakage
- Strength regained in a week
- Peritoneal adhesions
*
6.Factors Affecting Wound Healing
- Systemic
- Age
- Nutrition
- Smoking
- Metabolic diseases(DM,Metabolic syndrome)
- Drugs: corticosteroids,immunosup,chemo
- CT disorders - Ehler-danlos,marfan syndromes
- Local
- Hypoxia
- Mechanical injury
- Infection
- Edema
- Irradiation
- Ischemia
- Foreign bodies
7.Chronic Wounds &Ulcers
Decubitus ulcers
- prolonged pressure⇒tissue ischemia
- prolonged contact with moisture,urine,feces
- malnutrition
- in immobile,elderly,operated patients
- Treatment:
- drainage of infected space
- excision of necrotic tissue
- musculocutaneous flap
7.1.Chronic Wounds & Ulcers
Venous Ulcers
- poor perfusion and perivascular leakage of plasma
- lower leg
- Treatment: compression stocking,surgical treatment of vein insufficiency
Ischemic Ulcers
- Lateral ankle and foot
- Treatment: revascularisation,hyperbaric oxygen
7.2.Chronic Wounds & Ulcers
Diabetic Ulcers
- Neuropathy⇒trauma
- Microangiopathy⇒ischemia
- Treatment: protection of the ulcer,revascularisation
Treatment of wounds & ulcers
- Control infection w/ antibiotics
- Treat underlying circulatory disease
- Keep wound moist
- Debridement of unhealthy tissue
- Reduce autonomic vasoconstriction
8.Excess Healing
Excess dermal scarring
- Hypertrophic scar if epithelization takes longer than 3-4 wks
- Keloid
- 3 months after surgery
- keloidal fibroblasts synthesize 20x
- treat with local steroid injection
Peritoneal scarring(adhesions)
- Fibrin,fibroblasts &collagen⇒filmy adhesions
- Fibrinolysis w/in a week
- Migration of capillaries,nerves,CT⇒solid adhesions
9.Wound Management
Classification
- I.Clean:
- uninfected,no inflammation
- elective surgical wounds
- e.g.hernia,breast surgery
- management: primary closure
- Infection rate : <2%
- II.Clean-contaminated:
- Minor and brief contamination,minor inflammation
- Clean and sharp with local damage
- e.g.gastric surgery
- management: primary closure and wound cleaning
- infection rate : 1-5%
9.1.Wound Management
Classification
- III.Contaminated:
- Contamination apparent and prolonged,major inflammation
- Ragged and contused wounds w/ gross local damage
- E.g. inflamed appendectomy,penetrating wounds
- management: copious irrigation,debridement and primary closure
- infection rate : 5-25%
- IV.Dirty:
- Gross contamination w/ infection
- Old traumatic wounds >12h
- Severe tissue damage and excessive ischemic tissue
- e.g. abscess,perforated bowel
- management healing by secondary intention
- infection rate : 50%
10.Assessment of Wound Mechanism
- Kinetic energy injury -closed -blunt
- Kinetic energy injury-open-penetrating
- low energy -knife
- high energy - bullet
- Thermal injury
- Heat
- Frost
- Chemical injury
- Electrical injury
11.Surgical Management of Wounds
- Wound evaluation :
- mechanism of injury
- extent of injury and wound type
- decision for wound closure
- Patient consent
- Antimicrobials : tetanus prophylaxis
- Wound prep and sterile field
- Anesthesia
- Debridement-washing
- Hemostasis
- Closure
- Dressing
12.Other skin closure options
- Adhesive tapes
- (+) rapid, simple, no risk of needle injury
- (-) needs dry skin,poor adherence,poor hemostasis,accidental removal
- Skin glue
- (+) rapid,simple,reduced pain,good aethetic result
- (-) poor approximation of deep layers,poor hemostasis
- Surgical skin staples
- (+) fast closure of large wounds,less rxn than sutures
- (-) poor hemostasis
13.Surgical instruments
- Cutting instruments
- Scalpels
- Scissors -for tissues and sutures
- Grasping instruments
- Tissue forceps
- Ratcheted tissue forceps
- Needle-holders
- Retracting instruments
- Hand-held retractors
- Self-retaining retractors
13.1.Surgical instruments
Surgical staplers
- Skin stapler
- Linear stapler
- Gastrointestinal anastomosis stapler
- Circular stapler
13.2.Surgical Instruments
Energy applying instruments
- Diathermy
- Electrocoagulation
- Monopolar- patient return electrode
- Bipolar
Other energy applying instruments
- Mechanical energy (ultrasound scalpel)
- Laser
- Cyrotherapy
- Radiofrequency needles
13.3.Surgical Instruments
Sutures and Needles
- Suture materials
- Absorbable : polyglycolic acid,polydioxanone
- Non absorbable : polypropylene,polyamide
- Suture strand type
- Monofilament
- Multifilament
- Twisted
- Braided
- Suture size : 10/0 - thinner than 1
13.4.Surgical Instruments
Sutures and needles

14.Local Anesthetics
- Inhibit electrical conduction along neurons
- Transient blocking of Na+ transport channels in the cell membrane ⇒ blocks initial depolarization
- sensory neurons are more sensitive than motor neurons
- Lidocaine : 20mg/ml with or w/o adrenaline
- Bupivacaine : 5mg/ml
- Ropivacaine : 7.5 mg/ml
- onset : 5-10 mins, duration 1-6 hrs
14.Local Anesthetic Uses
- Topical
- Lipid soluble cream
- Extent of action :skin and mucosa up to few mm deep
- Local infiltration
- injected into tissue
- local nerves
- Nerve block
- Injected around a nerve or plexus
- Distribution of nerve blocked
- IV block
- IV injection in arterial tourniqueted limb
- Nerve tissue within limb
- Centrineural block
- Epidural or spinal injection
- Multiple dermatomes
- Cavity administration
- intrapleural or intraperitoneal admin
- local nerves in cavity
15.Local Anesthesia Toxicity
- Side effects
- Mouth and tongue numbness
- Anxiety
- Tremor
- Drowsiness
- Tachypnea
- Hypotension
- Nausea & vomiting
- Allergy
16.Local infiltration anesthesia
- Lidocaine
- time to onset : 5-10 min
- dilution : 2% lidocaine - max dose 300 mg for a 70 kg person
- # 23 blue or #25 orange needle
- infiltration technique : inject around site of incision
17.Basic Surgical Skills
- Suturing
- simple interrupted sutures
- running (continuous) sutures
- Knot tying
- Incisions & excisions
- elliptical excision : to take out a lesion
- incision
- Wound debridement
- Hemostasis
- with electrocoagulation
- with ligature
- Dissection
- blunt dissection
- sharp dissection
18.Sterile Technique
- Sterile : all forms of microbial life destroyed
- Aseptic : free from pathogens
- Disinfection: process of destroying all pathogens
- Clean : absence of gross contamination or dirt
Principles
- Reduction of env. contamination
- Disinfection of procedural site
- Isolation of procedural site
- Sterilization of procedural tools
19.Reduction of Environmental Contamination
- Clean OR staff
- clean clothing
- hair and beard covered
- OR shoes
- face mask
- Clean hands
- hand washing (scrub or hydroalcoholic rub)
- Clean air
- closed OR
- laminar airflow
- Clean equipment
- no touching
20.Disinfection of Procedural Site
- Cleaning
- washing to remove macroscoping contamination
- hair removal
- painting skin with antibacterial solution
- chlorohexidine 0.5%, povidone iodine 10%
21.Isolation of Procedural Site
- Gowning and gloving
- sterile gowns
- sterile gloves - sometimes double gloving
- no touch technique
- Draping
- exclusion of operative site w/ sterile towels or shet
- two layers
- raised sterile curtain btw anesthesist & surgeon
22.Sterilization of procedural tools
- Steam:
- Sterilization of all metallic instruments
- Sterilization in packs
- 20 PSI / 126C / 10 min
- Autoclave, flash sterilizes
- Dry heat:
- 160C/ 1h
- Chemical:
- Gas (ethylene oxide)
- Liquid (glutaraldehyde) - 10h soaking
- Plasma (ionized hydrogen peroxide gas)
- Sensitive equipment (endoscopes) : soaked in disinfectant
23.Surgical Team Safety
Body fluids and substances
- Risk of HBV,HCV,HIV
- Avoidance of contact w/ mucosas and skin
- Universal precautions
Sharps and needles
- Risk of injury from scalpels,needles
- Handling,returning & handing over sharp instruments
- Never recap needles
- Never place sharps on pt
- Protect needle point with needle holder
Other hazards
- Radiation exposure
- Electrical shock from equipment
- Toxic substances
24.Patient Safety
Preparation for the procedure
- Patient consent
- Correct patient, correct operation,correct side - mark lesion
- All lab and radiology tests available
- Any pt allergies or important info known
Positioning on operating table
- No metal to skin contact
- No pressure points
- No abnormal traction or angulation of limbs
- Mechanical DVT prophylaxis
- Eyes taped shut to prevent drying
- Stabilization of pt to avoid movement
24.1.Patient Safety
Procedure
- Injury from sharps
- Injury from retractors
- Electrocoagulation,lasers gauzes
- Breach in sterile technique
After procedure
- Risk in transfer from the OR table (tube displacement, injury)
- Post anesthetic observation
25.Systemic Inflammatory Response Syndrome
- Inflammatory response to injury
- Two or more of the criteria:
- T ≥ 38oC or ≤ 36oC
- HR ≥ 90/min
- RR ≥ 20/min
- WBC ≥ 12000/mm3 or ≤4000mm3
- Balance⇒Recovery
- Proinflamatory phase (SIRS)
- Counter - regulatory anti inflammatory response syndrome (CARS)
- Mixed antagonist response syndrome
- Imbalance ⇒ Multi Organ Failure (MOF)
26.Sepsis and Septic shock
- Sepsis : Suspected documented infection + an acute increase of ≥ SOFA points
- Septic shock :
- Sepsis + persisting hypotension that requires vasopressors to maintain MAP of 65mmHg
- Serum lactate level > 2mmol/L (18mg/dL) despite adequate volume resussitation
27.Sequential Organ Failure Assesment Score

28.Acute Phase Proteins
- Non-specific proteins secreted in response to tissue injury
- Produced by liver
- Biomarkers of systemic inflammation
- CRP - normal < 1 mg/dL
- Procalcitonin - normal < 0.15 ng/mL
- IL-6
- CNS inflammatory regulation
Autonomic regulation of:
- HR, BP,RR,GI motility
- Body temp
- Pro-inflammatory vs anti-infammatory response
Afferent Signals
- Inflammatory mediators
- TNFa
- Parasympathetic sensory input
- Cytokines TNFa,IL-1
- Baroreceptors
- Chemoreceptors
- Thermoreceptors
29.1 CNS inflammatory regulation
Cholinergic anti-inflammatory response
- Ach receptors on tissue macrophages : Ach reduces tissue macrophage release of proinflammatory mediators
- Ach reduces macrophage activation
- Effect of PS on HR, Gı motility, arteriole dilation
30.Hormonal Response to Injury
Pathways
- Receptor kinases
- G-protein receptors
- Ligand gated ion channels
ACTH- from anterior pituitary
- glucocorticoid production
Cortisol & Glucocorticoids - adrenal cortex
- Hyperglycemia - release of FFA & TG from fat cells, immunosuppression, down-regulation of pro-inflammatory cytokines

31.Inflammatory Mediators
- Cytokines
- Heat shock proteins (protection from stress)
- Oxygen radicals
- Eicosanoids - endocrine,immune,vasomotor funct.
- FA metabolites : attenuation of inflammatory resp.
- Kallikrein-kinin sys : vasodilation, ↑ capillary permeability
- Serotonin : vasoconstriction,bronchocons.,inotrope
- Histamine : hypotension, ↑capillary permeability
32.Endothelium mediated injury
- ↑ vascular permeability during inflammation
- facilitate O2 delivery
- facilitate immunocyte migration
- ischemia reperfusion injury
- accumulation of neutrophils
- unleashing O2 metabolites,lysosomal enz
- oxidation of basal membranes
- microvascular thromboses
- Endothelium hypoxia,endotoxins,injury and sheer stress produce
- NO -smooth m relaxation
- Prostacyclin - vasodilation & platelet activa.
- Endothelins - most potent vasoconstrictor
- Platelet-activ factor - activates neut,platelets - ↑ vascular permeability
- Atrial Natriuretic Peptides -vasodilation,fluid & electrolyte secretion, aldosterone inhibitors
- Causes of Fluid and electrolyte imbalance
- Surgical trauma - sepsis
- 3rd space fluid isolation
- Peri-operative fasting
- Vomiting
- Diarrhea
34.Body Water
- Total body water = 50-60% of total body weight
- Tissue water concentration
- Muscle-solid organs > fat
- New born>adult>elderly
- Male>female
- Lean>obese
35.Fluid Compartments
- Intracellular fluid : 40% of total body weight
- K+ : 150mM , Na+: 15mM, Mg2+: 40mM, Ca2+: minimal
- Phosphates,sulfates:150mM,HCO3- : 10mM, proteins : 40mM
- Extracellular fluid : 20% of total body weight
- Interstitial fluid 15%
- Plasma 5%
- Na+ : 142mM, K+: 5mM,Ca2+: 5mM,Mg2+:2mM
- Cl-:103mM,HCO3- : 26 mM,Phosphates: 2mM,Sulfates :1mM, Proteins: 17 mM
36.Body Fluid Osmolality
- Total solute concentration : mOsm/kg
- 290-310 mOsm/kg
- water diffuses freely between compartments
37.Fluid Sodium
- Sodium is confined to ECF
- Sodium containing fluids
- expansion of intravascular space - 5%
- 3x expansion of interstitial space - 15%
- Daily solute balance
- Oral intake : 2000 mL
- Cell metabolism : 400 mL
- Urinary excretion: 1500 mL
- Stool: 200 mL
- Skin,Lungs: 600 mL
39.Fluid Volume & Osmolality Control
- Baroreceptors
- Pressure sensors in aortic arch & carotid sinuses
- Osmoreceptors
- Sensors that detect changes in osmolality,kidney
- Hypothalamus⇒vasopressin ⇒renin-angiotensin-aldosterone⇒atrial natriuretic peptide⇒reduction in expanded ECF
40.Body Fluid Disturbances
- Volume disturbances
- Volume deficit
- Volume excess
- Electrolyte concentration disturbances
- Acid-base imbalance
41.Extracellular Volume Deficit
Causes in surgical patients:
- Inability to ingest water
- Loss of GI fluids :
- Nasogastric tube suction
- vomiting
- diarrhea
- enterocutaneous fistula
- Fluid isolation
- soft tissue injuries
- burns
- peritonitis-sepsis
- ileus-obstruction
41.1.Extracellular Volume Deficit
Clinical observations
- Weight loss 1kg/1L
- ↓ skin turgor
- Sunken eyes
- Tachycardia
- Hypotension
- Oliguria
- Confusion
Lab exam:
- ↑BUN,↓GFR
- ↑BUN: Creatine ratio
- ↑Hematocrite
- ↑urine osmolality (higher than serum)
- ↓urine sodium (20mEq/L)
42.Extracellular Volume Excess
Causes:
- Iatrogenic
- Renal dysfunction
- Heart failure
- Cirrhosis
- Inappropriate secretion of antidiuretic hormone
Clinical observations:
- Weight gain
- Peripheral edema- limb swelling
- ↑central venous pressure
- distended jugular veins
- pulmonary edema - fine crackles
- cardiac insufficiency - gallop rhythm
Lab exams:
- ↓ hematocrite
- ↓ urine osmolality
43.Electrolyte Disturbances
Sodium
- Na+ : predominant electrolyte of ECF
- Na+ concentration influences fluid osmolality
- Changes in Na+ are inversely proportional to total body weight
- Serum Na+ : 135-145 mEq/L
Hypernatremia
- causes:
- high volume
- gain of Na+ in excess of water
- hyperaldosteronism,cushing syndrome
- normal or low volume
- loss of free water (renal,GI tract,DI)
- high volume
43.1.Electrolyte Disturbances
Sodium
Clinical Observations of Hypernatremia
- Thirst
- If Na+ concentration > 160mEq/L
- Cellular dehydration - extracellular water shifting
- CNS symptoms - restlessness,irritability,seizures,coma
- Musculoskeletal - weakness
- If hypovolemic hypernatremia
- Tachycardia
- Orthostatic hypotension
Lab exams : serum Na+ > 145 mEq/L severe if > 160, urine specific gravity SG > 1.030 if nonrenal water loss

43.2. Electrolyte Disturbances
Sodium
Hyponatremia
Causes:
- Dilution
- Iatrogenic
- Polydipsia (psychogenic,DM, DI)
- Severe hyperglucemia (glc osmosis)
- Secretion of ADH (post trauma,surgery)
- Drugs (ACEI,antipsychotics)
- Depletion
- Low Na+ diet
- GI losses (vomiting,nasogastric suction)
- Renal losses (diuretics,renal diseases)

43.3.Electrolyte Disturbances
Sodium
Clinical observations of hyponatremia
- If severe - < 120 mEq/L
- CNS - seizures, coma,↑intracranial pressure
- Musculoskeletal - weakness,fatigue,cramps
- Rapid correction of severe hyponatremia⇒ osmotic demyelination syndrome
Lab exams:
- Serum Na+ < 135 mEq/L
- Low urine Na+ concentration < 20 mEq/L if extrarenal losses
- High urine Na+ concentration > 20 mEq/L if renal losses
44.Electrolyte Disturbances
Potassium
- Predominant intracellular cation
- Only 2% of total body K+ is extracellular while 98% is intracellular
- Critical to cardiac and neuromuscular function
- Serum K+ : 3.5-5 mEq/L
Hyperkalemia : K+ > 5mEq/L
Causes:
- Excesive K+ intake - supplements, blood transfuse
- Cell destruction - hemolysis,crush injury
- K+ extracellular shifting - acidosis
- Impaired kidney K+ secretion -K sparing diuretics,renal insufficiency
44.1.Electrolyte Disturbances
Potassium
Clinical Observations of hyperkalemia
- GI - nausea,vomiting,colic
- Neuromuscular - weakness,paralysis
- Cardiovascular - arrythmia,arrest
ECG alterations
- Peaked T waves, flattened P wave
- Prolonged PR interval
- Widened QRS
- V-fib

44.2.Electrolyte Disturbances
Potassium
Hypokalemia : K+ < 3.5 mEq/L
Causes:
- ↓ intake - inadequate oral or iv K+
- Intracellular K+ shifting - alkalosis
- Excessive K+ renal excretion - diuretics,hyperaldosteronism
- GI losses - diarrhea,vomiting,fistula
44.3.Electrolyte Disturbances
Potassium
Clinical observations of hypokalemia
- GI- ileus,constipation
- Neuromuscular-↓reflexes,fatigue,weakness,paralysis
- Cardiovascular-PEA,asystole
ECG alterations
- U waves
- T-wave flattening
- Arrythmias

45.Electrolyte Disturbances
Calcium
- contained in bone matrix 99%
- serum calcium - 50% ionized (free) and 50% bound (protein & phosphate complexes)
- total serum Ca2+ is measured but the ionized is responsible for neuromuscular stability
Hypercalcemia
Causes:
- primary hyperparathyroidism
- malignancy - bone metastases,secretion of PTH related protein
Clinical observations
- GI - nausea,vomiting,abdominal pain
- Neuromuscular - weakness,confusion,coma,pain
- CV- hypertension,arrythmia,ECG alterations
45.1.Electrolyte Disturbances
Calcium
Hypocalcemia : Ca2+< 8.5 mEq/L
Causes:
- Hypoparathyroidism
- Other - pancreatitis,renal failure
Clinical observations:
- In severe hypocalcemia
- Neuromuscular - hypereflexia,tetany,Chvostek’s sign (spasm of facial m. when facial n is tapped at lvl of jaw),Trousseau’s sign (carpal spasm induced by BP cuff), bone pain
- CV - heart failure, ECG alterations
46.Electrolyte Disturbances
Magnesium
- Predominantly intracellular
- 1/3 serum Mg is albumin bound
- Normal serum Mg2+ = 1.5-2.5 mg/dL
Hypermagnesemia
Causes:
- Excess intake - Mg laxatives and antacids
- Renal failure
Clinical observations
- GI - nausea,vomiting
- Neuromuscular- weakness,vomiting, ↓reflexes
- CV-hypotension,arrest,ECG alterations like hyper-K
46.1.Electrolyte Disturbances
Magnesium
Hypomagnesemia : Mg2+ < 1.5 mg/dL
Causes:
- common in hospitalized patients
- poor intake
- ↑ renal excretion - alcohol, diuretics
- GI losses - diarrhea
- acidosis
Clinical observations
- Neuromuscular - hyperactive reflexes,tremors,tetany,seizures
- CV - ECG alterations-torsade de pointes,arrest
- can produce hypocalcemia
- can cause persistent hypokalemia

47.Electrolyte Disturbances
Phosphorus
- primarily a constituent of bone
- predominant intracellular anion HPO43-
- abundant in metabolic active cells : high energy phosphate products (ATP)
- controlled by urinary secretion
- serum phosphorus : 2.5-4.5 mg/dL
Hyperphosphatemia : P-3 > 4.5 mg/dL
Causes
- ↓ urinary excretion
- ↑ intake - phosphorus rich laxatives
- ↑ production- cell destruction
Clinical observations
- asymptomatic
- high calcium-phosphate product⇒calcifications
47.1.Electrolyte Disturbances
Phosphorus
Hypophosphatemia : P-3 < 2.5 mg/dL
Causes:
- poor dietary intake - alcoholism
- antacid administration- binding of P in bowel
- hyperparathyroidism
Clinical observations:
- When severe hypo-p <1 mg/dL
- Neuromuscular - fatigue,weakness,convulsions
- CV- impaired heart contractibility
- Osteomalakia-chronic depletion
48.Acid Base Balance
- Daily metabolism produces 1 mEq/kg of H+
- Produced CO2 is transformed to H2CO3
- Buffering systems
- intracellular proteins- hemoglobin
- extracellular bicarbonate/carbonic acid
H++HCO3- ⇔ H2CO4⇔H2O +CO2
pH = pK + log ( [HCO3- ] / 003 x PCO2
- PCO2 ⇒ regulated by pulmonary ventilation
- HCO3- is regulated by the kidney
- HCO3- reabsorption
- Secretion of H+
- Secretion of NH4+
49.Normal Values
- pH is regulated at 7.35-7.45
- Acidemia ⇒ pH < 7.35
- Alkalemia ⇒ pH > 7.45
- HCO3- : 22-26 mmol/L
- PCO2 : 35-45 mmHg
Anion gap
- UA-UC = [Na+] - ( [HCO3-] +[Cl-]) : 3-11 mEq/L
50.Respiratory Acidosis
- PCO2 > 45 mmHg
Acute respiratory acidosis
- Acute respiratory failure - obstruction,aspiration
- PCO2 ↑
- HCO3- stable
- pH↓ - acidemia
Chronic respiratory acidosis
- Chronic respiratory failure
- PCO2 ↑
- HCO3- ↑ - compensation - renal NH4 excretion
- pH normalized

51.Respiratory Alkalosis
- PCO2 < 35 mmHg
Acute respiratory alkalosis
- Acute hyperventilation - psychogenic,sepsis
- PCO2 ↓
- HCO3- stable
- pH ↑ - alkalemia
Chronic respiratory alkalosis
- PCO2↑
- HCO3- ↑
- pH normalized

- Metabolic Acidosis
- HCO3- < 22 mmol/L
- Excessive HCO3- - diarrhea, diuretics
- HCO3- ↓
- Cl- ↑
- Anion gap is normal N = 3-11 mEq/L
- hyperchloremic metabolic acidosis
- Excessive lactate,acetoacetate,b-hydroxybutyrate
- Addition of unmeasured anions
- Anion gap is ↑
- HCO3- ↓ - consumption

53.Metabolic Alkalosis
- HCO3- > 26 mmol/L
- Causes
- Loss of H+ ⇒ ↑ in HCO3- (vomiting,ng suction)
- Impaireed renal exertion of HCO3-
- Associated hyperchloremia
- Volume depletion

54.Respiratory & Metabolic Components of Acid-Base Disorders

55.Principles of Fluid & Electrolyte Therapy
- Surgical patients need fluids
- None by mouth ⇒ IV
- Maintenance of fluids
- Volume replacement
- Bleeding
- Sepsis
- GI losses
- Evaluation of the fluid volume deficit
- Calculation of ongoing fluid losses
- Assessment of Na+,K+ requirements
- Management of acid-base disturbances
56.Volume and Electrolyte Content of GI Fluids

57.Types of Replacement Fluids
Crystaloids
- Solutions of water w/ electrolytes
- Solutions of water w/ glucose
Colloids
- Solutions of high molecular weight macromolecules
58.Parenteral Electrolyte Solutions
Crystaloids

59.Parenteral Electrolyte Solutions
Colloids

- Replacement Fluid Guidelines
- Maintenance fluids : 30-40 ml /kg/day
- Replace all losses volume for volume
- Isotonic vs hypotonic vs hypertonic
- No K+ for the early post-operative period
Infused fluids distribution
- Glc solutions ⇒ 2/3 intracellular , 1/3 extracellular
- Na+ solutions ⇒ 1/4 intravascular, 3/4 interstitial
- Colloids⇒ intravascular space
- ASA Physical Status Classification

- Altered State Patient
Nutritional Assessment
- Anticipated post-operative fasting
- Dietary history
- Weight loss > 10%
- Serum albumin < 3 g/dL, transferrin < 150 mg/dL
Immune incompetence
- Elderly patients, malnutrition,cancer,severe burns
- Total lymphocyte count
- Skin tests (anergy)
Infectious risk
- Drugs : corticosteroids, immunosuppressors,cytotoxic drugs, prolonged antibiotic therapy
- Renal failure
- Granulocytopenia
- Hematologic diseases: lymphomas,leukemias,hypogammaglobulinemia
- Uncontrolled diabetes
63.Patient with Pulmonary Dysfunction
- Risk of post-operative complications : hypoxia,atelectasis,pneumonia
History
- Heavy smoking >20 PY
- Cough - character sputum,Wheezing
- Exercise intolerance
- Obesity
- Old age
- Known pulmonary disease
Physical exam
- Wheezing, prolonged expiration
Lab tests
- Chest x-ray, ECG
- Arterial blood gases - CO2 retention - respiratory acidosis, pulmonary function tests - FVC,FEV1
64.Delayed wound healing
Patient at risk
- Hypoproteinemia
- Vit C deficit
- Volume disorders - edema/dehydration
- Anemia
- Diabetes
- Smoking
- Corticosteroids- in large doses
- Cytotoxic chemotherapy
- Irridation
65.Drug effect
Drug allergies
- Penicillin/antibiotics
- Morphine/opioids
- Xylocaine-local anesthetics
- Aspirin/NSAIDS
- Tetanus antitoxin
- Iodine-other antiseptics
- Other drugs,Food,Adhesive tape
Drug adaptation
- Digitalis,insulin,corticosteroids⇒continuation
- stress dose of corticosteroids- hydrocortisone 100 mg x3
- Oral anticoagulation drugs replaced w/heparin
- Oral antidiabetics replaced w/ insulin during fasting
- CNS depressants - barbiturates,opioids,alcohol,chlorpromazine
- Antihypertensives
66.Patient at Risk of Thromboembolism
Patient risk factors
- Cancer
- Obesity
- MI
- Age >45
- History of thromboembolic event
Surgery
- General,pelvic,orthopedic surgery
DVT prevention
- Early postoperative mobilisation
- Mechanical : graduated compression stockings,intermittent pneumatic compression
- Chemical : unfractioned heparin,low molecular weight heparin

67.Elderly Patients
Physiological vs chronological age
- CV,renal,other systemic diseases
Patients > 60
- Arteriosclerosis
- Cardiac reserve limitation
- Renal reserve limitation
- Occult cancer
Avoid volume overload
- fluid intake and output
- body weight
- CVP
Adapted doses of drugs
- Narcotics
- Benzos can cause agitation
68.The Obese Patient
Metabolic Syndrome
- ↑BP, ↑ blood sugar lvl, ↑↑↑ body fat around waist, abnormal cholesterol levels
Risk of concominant disease
- Heart disease
- Stroke
- Diabetes
Wound complications
69.Preoperative Patient Preparation
- Preoperative hyperalimentation (7-10d)
- Pulmonary prep for > 48h
- Abstinence from smoking
- Inhaled bronchodilators
- Chest physical therapy x2 a day
- Inspiratory effort exercise devices
- Maintain blood volume and tissue perfusion
- Avoid dehydration/volume deficit
- Drug adaptation
- Thromboembolic prophylaxis
- Fasting for 6h (solids) & 2h (liquids) before major operations or general anesthesia
70.Preoperative Formalities
- Patient info
- Surgeon
- Diagnosis
- Planned surgical procedure
- Risks & possible complications
- Need for blood transfusion
- Postoperative recovery
- Anesthesiologist
- Type of anesthesia
- Anesthesia related risks
- Postanesthesia recovery
- Surgeon
- Signed informed consent
- Signed by pt or legal guardian of minors
- Emergency lifesaving operations
71.Operative Field Preparation
Initial prep- evening before operation
- Washing w/ soap and water
- No shaving - ↑ skin infection risk
- Marking of operative site by surgeon
In operating room
- Hair clipping if required
- Skin prep w/ 2% iodine in 90% alcohol - for > 1 min, avoid using in perineum,genitelia,face,avoid spilling outside operative field
- Universal precautions
- Barrier protections
- Avoid accidental injuries
- Avoid contact of open wounds w/ pt
- Check gloves for tears
72.Control of Hospital Cross-Infections
Surgical infection control program
- Target of < 1% of clean wond infection rate
- Cultures and antibiotic sensitivity on all infections
- Isolation of pt w/ communicable infections
- Aseptic technique
- Isolation of OR
- Dressing of open wounds
- Hand washing
- Antibioprophylaxis
- For clean-contaminated & contaminated cases
- For clean cases if implanted material
- Give 1h to 30 min before incision
- 2nd gen cephalosporin,single dose. Repeat after 4h of surgery or major blood loss
73.Immediate Post-operative - Post-anesthetic Phase
Postanesthesia Care Unit
- Monitoring for 1-3 hrs post-op
- Discharge when cv,pulmonary & neurological functions normalized
Discharge w/ written post-op orders to
- Ward
- ICU /High dependency unit
74.Post-operative orders
- Monitoring
- Vitals
- ECG monitor
- CVP,PCWP
- Fluid input/output
- Respiratory care
- Position in bed and mobilization
- pt turned every 30 min til conscious
- change position every 1h for first 8-12h
- early mobilization
- Diet,Fluids & electrolytes,
- Medications : analgesics,dvt prophylaxis,gastric acid suppression etc
- Lab & imaging exams
75.Intermediate Postoperative Period
After complete recovery from anesthesia & transfer to ward
- Wound care
- Keep wound covered w/ sterile dressings for 2-3d post-op
- Soaked dressings replaced
- Dressing replacement on first 24h should be done w/ aseptic technique
- By 48h after closure, the skin wounds is sealed off from external env
75.1.Intermediate Postoperative Period
- Management of drains
- Prevent contamination of drain tract
- Handling of the drain w/ asceptic technique
- Early drain removal
- Post-op care of GI tract
- GI tract peristalsis return to normal after laparatomy :
- Small bowel w/in 24h
- Right colon after 48h
- Left colon after 72h
- Early normal feeding/enteral feeding
- GI tract peristalsis return to normal after laparatomy :
75.2.Intermediate Postoperative Period
Post-op pain control
- Parenteral opioids
- ↓ risk of addiction
- side effects : respiratory depression, nausea, vomiting, paralytic ileus
- NSAIDs
- side effects : GI ulcers, impaired coagulation, reduced renal function
- Paracetamol
- Patient controlled analgesia
- Continuous epidural analgesia
- Nerve blocks
76.Postoperative Complications
- Every complication that appears after operation
- May result from 1o disease, the operation, comorbidities, or unrelated factors
- Early detection
- Pre-op identification or risks & pt optimization
76.1.1.Postoperative Complications
Classification Systems
- Grade I :
- any deviation from normal post-op course w/out need for pharma treatment, or surgical endoscopic and radiological interventions
- Grade II:
- Requiring treatment w/ drugs other than such allowed for grade I complications.
- Grade III:
- Requires surgical,endoscopic or radiological intervention
- Grade IV:
- Life threatening complications (including CNS) requiring ICU-management
- Grade V:
- Death of patient
76.1.2.Postoperative Complications
Wound Complications
Seroma
- Fluid collection other than pus or blood
- After lymphatic transection
- Delay healing, infection risk
- Treatment: watchful wait, needle aspiration, compression dressing
Hematoma
- Collection of blood & clot
- Imperfect hemostasis
- Discomfort, compression effect, infection risk
- Risk factors: anticoagulants, aspirin, marked HT
- Treatment: evacuation of blood clot under sterile conditions & hemostasis
76.1.3.Postoperative Complications
Wound care
Surgical site infection
- Bacterial infection w/ inflammation and/or purulent collection
- Breach of aseptic conditions or operative contamination
- Risk factors: pt factors vs operation related factors
- Treatment: wound exploration/drainage, cultures, antibiotics
Pain
- Controlled by analgesics
- Pain ↓ on first 4-6 post-op days
- Persistent pain needs exploration - abcess, granuloma, incisional hernia

76.1.4.Postoperative Complications
Wound Complications
Ascitic leak
- Risk of wound infection and peritonitis
- Treatment: wound exploration (OR) & fascia closure
Wound dehiscence
- Partial & total disruption of any or all layers of wound
- Systemic vs. local factors
- Between 5-8 post-op days
- Discharge of serosanguineous fluid
- Dehiscence of laparatomy ⇒ evisceration
- Treatment: wound covered w/ moist towels, abdominal closure in OR
76.1.5.Postoperative Complications
Respiratory Complications
Atelectasis
- Bronchiole closure &/or obstruction from secretions
- Risk factors: old age, smoking, obesity, abdominal operations
- Diagnosis: fever, tachypnea, tachycardia, chest x-ray
- Atelectatic segments - risk of infection (pneumonia)
- Prevention: early mobilization, frequent changes in position, coughing, incentive spirometer
- Treatment: chest percussion,nasotracheal suction,bronchodilators,mucolytics
76.1.6.Postoperative Complications
Respiratory Complications
Pulmonary Aspiration
- Risk factors: NG tube, CNS depression, gastroesophageal reflux, intestinal obstruction, pregnancy, trauma patients
- Diagnosis: tachypnea, rales, hypoxia, cyanosis, wheezing
- Causes chemical pneumonitis & is a major risk of pneumonia
- Treatment: endotracheal suction, bronchoscopy, fluid resuscitation, antibiotics
76.1.7.Postoperative Complications
Respiratory Complications
Post-op pneumonia
- Risk factors: intubation, atelectasis, aspiration, bronchial secretions
- Microbes: g (-) bacilli, pseudomonas aeruginosa, klebsiella
- Mortality : 20-40%
- Treatment : Clearing of secretions, sputum cultures, antibiotics
76.1.8.Postoperative Complications
Respiratory Complications
Pleural effusion
- After upper abdominal operations, cardiac failure, pulmonary lesion, subdiaphragmatic inflammation
- Treatment: watchful wait, aspiration,drainage
Pneumothorax
- After pleural injury or positive pressure ventilation
- Treatment: thoracostomy tube
76.1.9. Postoperative Complications
Respiratory Complications
Cardiac complications
- Cardiac arrythmias
- due to reversible factors (hypo-K, hypoxia, acidosis, stress, drug toxicity)
- Pt w/ preexisting arrythmias
- Post-op MI
- 1/2 post-op MI are asymptomatic
- Postponing elective operations for 6 mo after MI
- Predisposing factors: hypoxia, hypotension, stress
- Post-op cardiac failure
- Left ventricular failure & acute pulmonary edema
- Predisposing factors: cardiac arrythmia, MI, volume overload, sepsis

76.2.Postoperative Complications
Peritoneal Complications
Hemoperitoneum
- W/in 24h of the operation
- Tachycardia, hypotension, peripheral vasoconstriction, oliguria
- Changes in Hct and Hg seen after 4-6h
- Radiological imaging - US, CT
- Patient stabilization, surgical treatment
76.2.1. Postoperative Complications
Complications of Drains
- Risk of drain tract infection
- Drain displacement
- Bleeding from drain tract
- Pain
76.2.2.Postoperative Complications
GI Motility Complications
Prolonged paralytic ileus
- Return of GI motility w/in 24h after non-abdominal surgery
- After laparotomy return of GI motility w/in 48h
- Paralytic ileus can last up to 5 post-op days
- No specific therapy
Bowel Obstruction
- From post-op adhesions or internal hernia
- Surgical treatment
76.2.3.Postoperatie Complications
GI Motility Complications
Gastric Dilation/Gastroparesis
- Massive distention of the stomach by fluid & gas
- Abdominal pain, distention and hiccups
- Risk of inhalation
- Gastric decompression w/ ng tube
Fecal Impaction
- Aggravating factors: opioids, anticholinergics, paralytic ileus
- Digital extraction, enemas
76.2.4.Postoperative Complications
Anastomotic Leak
- Healing failure of an intestinal anastomosis
- Usually 3-8d after surgery - up to 1 month
- Peritonitis: acute abdominal pain w/ rigid abdomen, tachycardia, high fevers & often hemodynamic instability
- Abscess: insidious presentation : low grade fever, prolonged ileus or failure to thrive
- Treatment options: surgical treatment, percutaneous drainage
76.2.5.Postoperative Complications
Liver and Pancreas Complications
Hepatic dysfunction
- Prehepatic jaundice
- Hemolysis
- Reabsorption of hematomas
- Hepatocellular insufficiency
- Hepatic cell necrosis (drugs, hypotension, hypoxia, sepsis)
- Massive liver resection
- After prolonged total parenteral nutrition
- Posthepatic obstruction
- Injury to the CBD
- Retained CBD stones
76.2.6.Postoperative Complications
Liver & Pancreas Complications
Postoperative cholecystitis
- Acalculous cholecystitis⇒risk of necrosis
- After ERCP-Endoscopic Retrograde Cholangiopancreatography
- After embolization of the right hepatic artery
Postoperative pancreatitis
- After operations in the vicinity of pancreas
- Mechanical trauma to the pancreas or its blood supply
- Drug induced pancreatitis (theiaazides, azathioprin, valproic acid)
76.2.7.Postoperative Complications
Clostridium Difficile Colitis
- Post-op diarrhea - pseudomembranous colitis
- From mild diarrhea to severe toxic colitis
- Diagnosis by IDing the toxin in the stool, bacteriology, endoscopy
- Prevention: hygiene, minimizing antibiotic use
- Treatment: metronidazole, vancomycin, fecal transplantation
76.2.8.Postoperative Complications
Urinary Complications
Urinary retention
- Interference w/ neural mechanism of micturition
- Bladder overdistention < 500ml
- Catheterization for operations longer than 3h, pelvic operations
- Encourage preoperative urination & soon after
UTIs
- Most frequent nosocomial infection
- Risk factors: catheter, urinary retention
- Cystitis, pyelonephritis
- Treatment: hydration, antibiotics
76.2.9.Postoperative Complications
IV and intraarterial catheters
Air embolism
- Accidental insertion of air in a central venous catheter
- Acute dyspnea, tachypnea, continuous cough, gasp reflex, neurological symptoms
- Position pt head down, right side up to trap air in right ventricle- supportive measures
Ischemic necrosis of fingers
- Ischemia due to indwelling radial artery catheter
- Patency of ulnar artery (Allen’s test)
- Early removal of arterial catheter
76.3.Postoperative Complications
IV and intraarterial catheters
Thrombophlebitis
- Common cause of fever
- Induration, edema, tenderness
- Prevention: aseptic technique, change of tubing, rotation of insertion site
76.3.1.Postoperative Complications
CNS & Psychiatric Complications
Postoperative stroke
- Due to poor cerebral perfusion-abrupt hypotension
- After carotid endarterectomy, open heart surgery w/ extracorporeal circulation
Delirium tremens
- Due to abrupt alcohol withdrawal w/in 2 weeks
- Personality changes, restlessness, confusion, overactivity, seizures
- Treatment: small amounts of alcohol, benzos
76.3.2.Postoperative Complications
CNS & Psychiatric Complications
Postoperative psychosis
- Elderly pt, severe systematic disease
- Present mood disturbances, confusion, fear, disorientation, delirium
- May be drug related: cimetidine, corticosteroids, benzos
- Eliminate metabolic derangements and early sepsis
ICU syndrome
- Due to pain, fear, sleep deprivation from bright lights
- Impaired cognitive ability, confusion, halucinations, delirium
76.3.3.Postoperative Complications
Postoperative Fever
- Post-op temperature elevation in 40% of pt
- w/in 48h
- After 2nd day : thrombophlebitis, pneumonia, UTI
- After 5d: Surgical site infection, anastomotic leak
- After 1w: Allergy, transfusion, sepsis, intraabdominal abscess
77.Shock
- Presence of tissue hypoperfusion that is insufficient to maintain normal aerobic metabolism
- Provokes sympathetic/paras & neuroendocrine stress response
- Leads to tissue hypoxia & end-organ dysfunction
- ↑ cardiac contractility & peripheral vascular tone
- hormonal response to preserve salt & intravascular fluid
- changes in microcirculation to regulate blood flow
- Persistent hypoperfusion w/ ↓ CO induce CV decompensation⇒ irreversible phase of shock, irreversible tissue injury and cell death
78.Neuroendocrine Response to Shock
Afferent signals to CNS
- Pain, infection, temp, hypoglycemia, emotional stress
- Volume receptors : heart atria
- Baroreceptors: aortic arch, carotid bodies
- Chemoreceptors: aorta, carotid bodies
Efferent signals to CNS
- CV response: ↑HR(B1),↑H.contractility(B1),Arterial vasoconstriction(a1)
- Hormone response:
- ACTH⇒cortisol
- Renin-angiotensin⇒aldosterone
- ADH
78.1.Neuroendocrine Response to Shock
Microcirculation
- Vasoconstriction of arteries & larger arterioles (a1)
- Vasodilation of distal arterioles (local factors)
- Diminished capillary hydrostatic pressure
- Shifting of fluid from EC space inside capillaries
- Capillary occlusion from endothelium cell swelling & neutrophil sludging
- Changes of microcirculation blood flow btw & w/in systems
79.Cellular Response to Shock
Oxygen tissue lvl ↓
- Mitochondrial dysoxia
- Anaerobic cell meetabolism (lactate production)
- Lactic acidosis
- Intracellular acidosis
Cellular ATP depletion
- Na+,K+, ATPase activity ↓
- Intracellular Na+ accumulation
- Cellular edema
- ↓ of cell membrane resting potential
Apoptosis
80.Immune & Inflammatory Response to Shock
Pro-inflammatory components
- TNFa
- By monocytes, macrophages, T-cells
- Induction of septic shock
- Peripheral vasodilation, pr breakdown, procoagulation
- IL-1B
- Half life of 6min
- Febrile response, anorexia
- IL-2
- By activated T-cells
- Activates lymphocytes
- Shock induced tissue injury
80.1.Immue & Inflammatory Response to Shock
- IL-6
- Causes lung, liver & gut injury after hemorrhagic shock
- Enhances activity of CRP, fibrogen, complement, neutrophil activation
- IL-10
- Immunosuppressive properties
- By T-cells, monocytes, macrophages
- Depression of cytocine production, oxygen radical production, adhesion
- IL-4
81.Forms of Shock
Hemorrhagic Shock
(hypovolemic)
- Loss of circulating volume from hemorrhage
- Sym activation⇒ vasoconstriction
- Renin-angiotensin-aldosterone activation⇒urinary Na+ and fluid retention
- ADH secretion⇒cerebral & coronary vessel autoregulation
Diagnosis:
- Capillary refill time >2sec
- Weak peripheral pulse
- Cold & clammy extremities
Treatment :
- secure airway & ventilation
- Hemorrhage control
- Fluid resuscitation

81.1.Forms of Shock
Cardiogenic Shock
- Circulatory pump failure ⇒tissue hypoxia in setting of adequate intravascular volume
- Hemodynamic criteria
- SBP < 90 mHg for more than 30 min
- Cardiac index < 2.2L/min/m2
- PCWP > 15mmHg
- Causes:
- Acute MI
- End-stage cardiomyopathy
- Myocarditis
- Valvular disease - aortic stenosis, mitral stenosis
- Mortality : 50-80%

81.1.2.Forms of Shock
Cardiogenic Shock
Diagnosis
- Signs of shock
- Physical exam
- cardiac murmur/sounds
- arrythmia
- acute pulmonary edema
- ECG
- Chest x-ray
- Heart ultrasound
- Invasive heart monitoring
- CVP
- PCWP
81.1.3.Forms of Shock
Cardiogenic Shock
Treatment
- Secure airway & ventilation
- Exclude hypovolemia
- Correction of electrolyte imbalance
- Inotropic support
- Dobutamine
- Dopamine
- Epinephrine
- Intra-aortic balloon pump
- Treatment of underlying disease
- PTCA +/- stent for acute MI
- Heart transplantation
81.1.4.Forms of Shock
Septic Shock
Vasodilatatory shock = failure of vascular smooth muscles to contract
- septic shock
- hypoxic lactic acidosis
- carbon monoxide poisoning
- terminal stage shock of any cause
Pathophysiology
- Derailment of SIRS ⇒vasodilation & hypotension⇒ ↑catecholamines,↑CO⇒R-A-Al activation ⇒ upregulation of iNOS in vessel wall
81.1.5.Forms of Shock
Septic Shock
Diagnostic criteria
- SIRS
- T > 38oC or < 36oC
- HR > 90/min
- RR > 20/min or PCO2 < 32 mmHg
- WBC > 12000/mm3 or < 4000/mm3 or bands > 10%
- Sepsis : SIRS + infection
- Septic shock : sepsis + tissue hypoperfusion
- SAP < 90 mmHg
- MAP < 65 mmHg
- SAP ↓ > 40 mmHg from baseline
- Lactate > 4 mmol/L
81.1.6.Forms of Shock
Septic Shock
Treatment
- Secure airway & ventilation
- Early hemodynamic optimization -6h
- Fluid resuscitation
- Vasopressors
- Infection control
- cultures
- antibiotics
- surgical source control
- Glycaemia control
- Immune modulation
- Activated protein C
- Cortisol
81.1.7. Forms of Shock
Neurogenic Shock
- Shock due to loss of vasomotor tone to peripheral arterial beds
- Cause: spinal corn injury or ischemia
Diagnosis
- ↓BP, bradycardia
- warm extremities
- motor and sensory deficit
- Radiographic evidence of spinal cord fracture
Treatment
- Secure airway & ventilation
- Fluid resuscitation
- Vasopressors : dopamine and phenylephrine (a-agonist)
81.1.8.Forms of Shock
Obstructive Shock
- Due to mechanical obstruction of venous return
- ↓ filling of right atrium (tension pneumothorax) ⇒ ↓ preload (cardiac temponade)
Diagnosis :
- Respiratory distress
- Hypotension
- Ipsilateral ↓ breath sounds
- Hyperresonance to percussion
- Tracheal deviation
- Distended jugular veins
Treatment : needle paracentesis, tube thoracostomy
81.1.9.Forms of Shock
Obstructive Shock
Cardiac temponade
Diagnosis
- High index of suspicion - injury mechanism
- Dyspnea
- Tachycardia & hypotension
- Chest pain
- Muffled heart sounds
- Distended jugular veins/ ↑ CVP
- Chest x-ray
- Echocardiography
Treatment: needle pericardiocentesis, left thoracotomy &pericardial window
81.2.Forms of Shock
Traumatic Shock
Systemic response after trauma
- Mechanism
- Soft tissue injury
- Long bone fracture
- Blood loss
- Pathophysiology
- Pro-inflammatory activation
- High incidence of ARDS
- Treatment
- Hemorrhage control
- Volume resuscitation
- Stabilization of fractures & treatment of soft tissue injuries
82.Endpoints Resuscitation
- Goal in treatment of shock : restoration of adequate organ perfusion & tissue oxygenation
- Endpoints for resuscitation
- O2 transport
- Lactate
- Base deficit
- Gastric tonometry
- Near infrared spectroscopy
- Tissue pH, O2,CO2
- Right ventricular and diastolic index
83.Fluid Resuscitation
Crystalloids vs Colloids
- Crystaloids more used, cheaper, better results in trauma patients
Albumin infusion : detrimental
- ↑mortality in hypovolemia, burns, hypoalbuminemia
Hypertonic saline (NaCl 7.5%)
- Outcomes of hemorrhagic shock : immunomodulation, intracellular liquid shifting
Blood transfusion trigger
- Hg 7-9 g/dL , Hg 10-12 g/dL for pt w/ cardiac disease
Hypotensive resuscitation
- Penetrating injury : SBP 80-90 mmHg
- Blunt trauma: SBP 110 mmHg
84.Nutritional Assessment
History
- Factors predisposing to malnutrition
- Absorption disorders (celiac sprue)
- AIDS
- Alcoholism
- Chronic renal insufficiency
- Cirrhosis
- DM
- Enteric obstruction
- IBS
- Malignancy
- Prolonged starvation
- Psychiatric disorders
- Recent major surgery,trauma or burn
- Surgical operations of GI tract
- Severe cardiopulmonary disease
84.1.Nutritional Assessment
Physical Examination

84.2.Nutritional Assessment
Lab tests

85.Nutritional Indices

86.Calculating Daily Energy Requirements
Basal Energy Expenditure
BEE(male) = 66.4 + [13.7 x weight in kg] + [5xheight in cm] - [6.8 x age]
BEE(female)= 655 + [9.6 x weight in kg] + [1.7xheight in cm] - [4.7 x age]
TEE = BEE x stress factor (1-1.8) kcal/day

87.Metabolism Energy Requirements
- Basal Metabolic Rate - 60% of TEE
- 50% ion pumping
- 30% pr metabolism
- 20% aa,glc,lactate &pyruvate metabolism
- Physical activity - 30% of TEE
- 10-50% for normal subjects
- 10-20% for hospitalized pts
- Thermic Effect of Food - 10% of TEE
- Energy expanded for digestion,absorption & metabolism of nutrients
88.Nutrient Requirements
Carbohydrates
- 1o energy source
- 30-40% of total caloric intake
- 4 kcal/g
- Digestion:
- salivary & pancreatic amylase
- absorption by first 1-1.5m of small bowel
- Min. intake of 400 kcal of CHOs / day minimizes pr takedown
- Glc necessary for hemopoietic system & CNS
88.1.Nutrient Requirements
Proteins
- Composed of 20aas
- 4 kcal/g of pr
- Digestion
- gastric peptin
- pancreatic proteases
- absorption at duodenum - 50% and mid-jejenum
- Protein turnover
- Total body pr 10-11 kg in a 70 kg person
- Daily pr turnover 250-300g
- Requirements : 0.8/kg body weight/day
- Nitrogen balance
- enteral + parenteral intake - urine losses-feces losses- other losses
- 6.23 g of pr = 1 g of N
- Urine nitrogen losses from 24h urine collection
- Index of pr synthesis & breakdown
88.2.Nutrient Requirements
Lipids
- 24-45% of caloric intake
- 9 kcal/g of lipid
- Digestion
- Bile salts⇒emulsification
- Pancreatic lipase,cholesterol esterase, phospholipase A2
- Lipolysis stimulated by steroids, catecholamines, glucagon. Inhibited by insulin
- Body can synthesize most lipids
- linoleic & linolenic LCFA are essential
- Minimum of 3% caloric intake as essential FA
88.3. Nutrient Requirements
Nucleotides & Vitamins
- Nucleotides
- Fat soluble vitamins : A,D,E,K
- Water soluble vitamins : B1, B2, B6, B12, niacin, folate, biotin, pantothenic acid
- Trace elements : Fe, Zn, Cu, Cr, Se, Mn, I
89.Starvation
Effects of fasting
- Overnight fast⇒ depletion of liver glycogen
- 24h fast⇒depletion of CHO stores
- First days⇒degredation of pr & fat
- depression of insulin
- breakdown of muscle pr
- liver gluconeogenesis from aas
- TG hydrolysis⇒FFA⇒energy for gluconeogenesis
89.1.Starvation
- Gluconeogenesis from aas
- Urinary nitrogen secretion of 8-12g/day (urea)
- Loss of 340g/day of lean tissue
- Loss of 35% lean body mass in 1 month ⇒death
- However : if sufficient water intake ⇒ starvation can be survived for 2-3 months
- adaptation of metabolism to conserve energy by recycling metabolic intermediates
89.2.Starvation
- Metabolic adaptations to chronic starvation
- After 10 days of starvation, brain starts using ketones as 1o fuel
- ↓ in basic metabolism
- ↓HR
- ↓ of voluntary activity
- ↑ in blood ketone levels
- ↓ in gluconeogenesis
- Urinary nitrogen excretion falls to 2-3g/day
90.Elective Operation or Trauma
- Neurohormonal activation
- Epinephrine,cortisol - adrenals
- Norepinephrine - sympathetic nerves
- ADH- post pituitary
- ACTH,TSH,GH - anterior pituitary
- Glucagon
- Peripheral lipolysis (glucagon,epinephrine,T3)
- Accelerated catabolism-proteolysis (cortisol)
- ↓peripheral glc uptake (GH,insulin)
- glc intolerance
- Water & Na urinary excretion
- 15-20g/day
- lean tissue loss of 750g/day - severe trauma
- W/out nutrients the median survival is 15 days
91.Sepsis & Nutrition
- Inflammatory cytokines
- TNFa, IL-1,IL-6
- Marked muscle catabolism
- Plasma glc, aas, FFA ↑
- Glc intolerance
- Urinary nitrogen excretion 20-30g/day
- Without nutrients the median survival is 10 days
92.Surgical Patient Diet
Surgical pt can’t eat :
- up to 6h before anesthesia
- under sedation
- before upper GI endoscopy
- after major upper GI procedures
- bowel obstruction
- paralytic ileus
Optimal diet:
- CHO 55-60% (230-275g/day)
- Fat 30% (70-75g/day)
- Protein 10-15% (95-100g/day)
- Cholesterol 300 mg/day - 1 egg yolk
- Salt 3g/day
- Fibers 25g/day
- Vitamins
- Total calories 2000-2500kcal/day - 30kcal/kg/day
93.Normal Diet
Benefits:
- Most physiological
- Metabolic benefits
- Production of gut immunoglobulins
- Easily accepted by patient
- Reduces post-op complications
- Safer
- Low cost
Problems:
- Cannot be used for paralytic ileus or bowel obstruction
- Risk of vomiting & inhalation
- Patient anorexia⇒inadequate caloric intake
94.Enteral Nutrition
- Food directly into the gut
- Blenderized food or special formulas
- Can be given with syrienge
- a pump controls the mixture administration rate
Benefits:
- Preferred method of nutritional support for pt unable or unwilling to eat
- Preserves gut functionality
- Blenderized foot may be given
- Lower cost than parenteral nutrition
Problems
- Cannot be used in pt needing bowel rest
- Delivery method requires a tube placement, dietary formulas, monitoring of feeding
- Technical problems (5%) - tube clogging or displacement
- Metabolic problems (25%) - nausea, vomiting, diarrhea, distension, hypernatremia, hyperglucemia
95.Parenteral Nutrition
- Nutrients given directly in blood
- Requires specialized sterile nutritional slns
- Circumvents digestive tube completely ⇒ bowel rest
- Route of administration : peripheral parenteral nutrition, total parenteral nutrition
Indications
- short bowel syndrome <100cm w/out colon, <50cm w/ colon
- ↑output enteric fistulas (>500ml/d)
- surgical pt w : prolonged paralytic ileus, multiple injuries or severe abdominal trauma
- severe intestinal malabsorption syndromes
- failure to maintain caloric needs w/ enteral nutrition
95.1.Parenteral Nutrition
Formulas
- 3-in-1 mixtures
- Dextrose 20-50%
- Aas 10%
- Fat emulsion 20%
- Electrolytes
- vitamins
- oligo-elements
- Benefits
- only method for pt w non functional digestive tube
- bowel rest
- Problems :
- requires sterile conditions, catheter, close monitoring
- technical problems : catheter clogging, displacement (embolism risk), infection(sepsis)
- metabolic problems : hyper-hypoglucemia, electrolyte disorders, liver steatosis, gut mucosal atrophy
95.2. Peripheral Parenteral Nutrition
- Given through a peripheral vein catheter
- Patients requiring nutritional support < 14 days
- To avoid phlebitis the solution osmolarity < 1000 mosm/L
- Great volumes of slns (>2.5-3L/day) are needed to fulfill caloric needs
95.3.Total Parenteral Nutrition
- Given through a central venous catheter (subclavian, internal jugular, femoral) or a peripheral inserted central catheter
- More concentrated slns - ↑osmolarity
*
- Hallmarks of Cancer
- Self-sufficiency in growth signals
- Insensitivity to anti-growth signals
- Evading programmed cell death
- Limitless replicative potential
- Sustained angiogenesis
- Tissue invasion & metastasis
- Deregulated metabolism
- Evading the immune system
- Genome instability
- Inflammation
97.Diagnosis of Cancer
- Fine needle aspiration biopsy
- cytological examination- no architecture
- breast lumps, lung nodules, thyroid tumours
- Core needle biopsy
- sliver of tissue for pathological exam
- radiological guidance
- Excisional biopsy
- removal of entire gross tumors
- Sampling of a representative area of a lesion
98.Tumor Grade
- Tumor grade is a histological determination of the degree of cellular differentiation
- ↑tumor grade ⇒ tumor is more biologically agressive
- tumor grade factors : nuclear pleomorphism, cellularity, necrosis, cellular invasion, # of mitoses
- Tumor grade is important for sarcomas, astrocytomas, Hodgkin & non-Hodgkin lymphomas, prostate cancer
99.Tumor Stage
- Denotes the extent of disease
- Most imprtant prognostic & therapeutic strategy deliminating factor
- Staging
- Clinical
- Pathological
- Staging systems
- TNM
- Stage I-IV
100.TNM Staging System
- Tumor - T
- 1o tumor extension
- T1-4
- Lymph Nodes - N
- Regional lymph node involvement
- N0-3
- Metastases - M
- Presence of distant metastases
- M0-1
101.Treatment
- Curative surgery
- resection of 1o tumor : R0,1 microscopic residual, R2 gross residual
- Lymphadenectomy
- Regional control
- Sampling - staging
- Sentinel lymph node - selective lymphadenopathy
- Resection of isolated metastases
- Adjuvant & neoadjuvant treatments
- Palliation
Control of pain, bleeding, obstruction, malnutrition, infection in unresectable advanced cancer
Surgical palliation
- malnutrition: vascular access, gastrostomy, jejunostomy
- Pain
- Oncological emergencies : hemorrhage, obstruction, perforation
- Indication for Prophylactic Surgery
Removal of an organ that is at high risk of developing cancer due to a present mutation
- ulcerative colitis ⇒ total coloproctectomy
- familial adenomatous polyposis coli ⇒ total colectomy
- multiple endocrine neoplasia (MEN2a&MEN2b)⇒total thyroidectomy
- BRCA1&2 ⇒ bilateral mastectomy
104.Cytotoxic Chemotherapy
- Curative : for hematologic, anal, testicular cancer
- Adjuvant : to improve survival after surgery
- Neoadjuvant : to facilitate surgical resection by shrinking 1o tumor, to convert an initially unresectable tumor to a resectable one, to test a tumor sensitivity to chemotherapy
- Palliative: to prolong survival &/or improve quality of life
- systemic vs regional administration
- Alkylating agents, platinum analogues, antimetabolites, antimicrotubule agents, topoisomerase inhibitors, antibiotics
- Hormonal Therapy
Blocking effects of hormones that stimulate proliferation
- Estrogen & androgen inhibitors
- Tamoxifen for estrogen sensitive breast c.
- Flutamide for prostate cancer
- GRH anologues : leuprolide ⇒ pharma castration for breast & prostate cancer
- Aromatase inhibitors : Anastroxol for metastatic breast c in postmenapause woman
- Somatostatin anagolues octreotide for neuroendocrine tumors of gut etc
106.Radiation Therapy
- Locoregional control
- Alone or in combination w/ surgery
- pre or post operative
- Mode of delivery
- teletherapyi brachytherapy
- Effect of radiation
- Electrons or ↑E photons, exposure : roentgens, absorbed dose : gray, ionization ⇒ creation of free radicals
107.Biologic Therapy
Molecular therapeutics exploit the molecular differences btw normal & cancer cells - targeted
- Monoclonal antibodies w/ specificity to tumor antigens
- Rituximab : anti CD20- non-hodgkin’s
- Cancer preventative vaccines
- HPV,HBV
- Immunostimulants & vaccines
- BCG infusion for superficial urinary bladder carcinoma
- Experiental biological therapy
- oncolytic virus therapy, gene therapy, adoptive T-cell cancer therapy
108.Prognosis
- Survival & disease free survival
- Tumor grade
- Tumor stage
- Optimized & customized treatment strategy
- Response to systemic treatment
109.Paraneoplastic Syndromes
- Cushing syndrome - ACTH-like
- Syndrome of inappropriate ADH-secretion
- Hypercalcemia- osteolysis- pthlike
- Venous thrombosis
- DIC
- Tumor Markers
Substances that can be deteted in ↑ than normal amounts in serum or body fluids of pts
- Prostate-specific antigen
- Carcinoembryonic antigen - colorectal cancer
- Alpha Fetopr-hepatocellular carcinoma
- Cancer Antigen 15-3,27-29-recurrence of breast c
- Chromogranin A-prognosis and monitoring of neuroendocrine tumors
111.Transplantation Definitions
- Allograft : an organ or tissue transplanted from one individual to another
- HLA : human leukocyte antigen, the main trigger to graft rejection
- Xenograft : a graft performed btw different species
- Orthotopic graft : a graft placed in its normal anatomical site
- Heterotopic graft : a graft placed in a site different from that where the organ is normally located
112.Transplant Immunology
- Allorecognition : IDing of antigen
- APCs + Alloantigen +MHC
- Bcells & antibodies
- Tcells
- Other cells : NK cells, monocytes/macrophages
113.Transplant Rejection
- Hyperacute rejection : antibodies bind to ABO blood group antigens
- Acute rejection : T-cells cellular, Bcells hormonal rejection
- Chronic rejection : fibrosis of small vessels
Diagnosis
- Clinical & biochemical impaired organ function
- Mild systemic immune symptoms : low grade fever, malaise, lymphocytosis
- Biopsy
- Immunosuppression masks symptoms

114.Immunosuppression & Side effects
- Corticosteroids,cancineurein inhibitors
- Mammalian target of rapamycin inhibitors
- Mycophenolic acid, anti-thymocyte globulin
Side effects
- Opportunistic infection : Cytomegalovirus, Pneumocytosis jiiroveci
- Malignancy : Post transplant lymphoproliferative disorders
- Transplant Donors
- Living donors
- Relatives or emotionally connected people
- Organs : kidney,liver lobe
- Minimal risk for donor
- Deceased donation : heart- beating, brainstem death, non-heart beating donors after circulatory death
- Registration as organ donor- agreement of next of kin
- Confirmation of brainstem death-irreversible structural brain damage
- Surgery for organ procurement
- Organ preservation
- Transplantation to receiver
116.Heart Transplant
- Indication : end-stage heart disease
- Matching donor recipient
- ABO compatibility
- Size match
- Technique : orthotopic heart
- Survival 5-year 65%
- Lung Transplant
- Indication : end-stage lung disease
- Matching donor to recipient
- ABO compatibility
- Size match
- Technique : orthotopic single lung, double lung, heart lung transplantation
- Survival : 5 year 40%
- Kidney Transplant
- Indication : end stage renal failure
- Matching donor to recipient
- ABO compatibility
- HLA typing
- Technique : extraperitoneal placement into iliac fossa
- Survival : 5-year survival 84%
- Pancrease & Islets of Langerhan Transplantation
- Indication: insulin-dependent diabetes - w/kidney transplantation
- Technique
- Pancreas transplantation: whole organ implanted intraperitoneally or right iliac fossa
- Islet cell transplantation: islet cells isolated & embolized into the donor liver through portal venous catheter
- Liver Transplantation
- Indication: end-stage liver disease, hepatocellular carcinoma
- Child-Pugh score C⇒ indication
- High MELD score - ↑er priority
- Technique:
- Orthotopic liver transplant
- Living donor- lobe-transplant
- Survival : 5 year graft survival 60%
- Small bowel transplant
- Indication : intestinal failure w/ life threatening TPN complication
- Short bowel syndrome <50cm
- High risk of acute rejection- gut immune cells